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Abstract
To overcome the limitations of the state-of-the-art influenza surveillance systems in Europe, we established in 2008 a European-wide
consortium aimed at introducing an innovative information and communication technology approach for a web-based surveillance system
across different European countries, called Influenzanet. The system, based on earlier efforts in The Netherlands and Portugal, works with the
participation of the population in each country to collect real-time information on the distribution of influenza-like illness cases through web
surveys administered to volunteers reporting their symptoms (or lack of symptoms) every week during the influenza season. Such a large
European-wide web-based monitoring infrastructure is intended to rapidly identify public health emergencies, contribute to understanding
global trends, inform data-driven forecast models to assess the impact on the population, optimize the allocation of resources, and help in
devising mitigation and containment measures. In this article, we describe the scientific and technological issues faced during the development
and deployment of a flexible and readily deployable web tool capable of coping with the requirements of different countries for data collection,
during either a public health emergency or an ordinary influenza season. Even though the system is based on previous successful experience,
the implementation in each new country represented a separate scientific challenge. Only after more than 5 years of development are the
existing platforms based on a plug-and-play tool that can be promptly deployed in any country wishing to be part of the Influenzanet network,
now composed of The Netherlands, Belgium, Portugal, Italy, the UK, France, Sweden, Spain, Ireland, and Denmark.
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Introduction
Infectious diseases remain a serious medical burden all around
the world, with 15 million deaths per year estimated to be
directly related to infectious diseases [1]. The emergence of
new diseases such as human immunodeficiency virus/AIDS and
SARS, and the rise of the new influenza strains H1N1, H5N1,
and H7N9, as well as other respiratory pathogens such as the
novel coronavirus Middle East respiratory syndrome corona-
virus, represent a few examples of the global problems facing
public health and medical science researchers. Even though
pathogens such as the SARS coronavirus and H5N1 had a
limited impact in terms of mortality, their sudden appearance
has shown how abruptly health emergencies on a global scale
can arise.
In recent times, our ability to control epidemic outbreaks
has been, to a high degree, facilitated not only by advances in
modern science (new cures, new drugs, and cooperative
infrastructures for disease control and surveillance), but also
by the worldwide spread of new technologies such as
computers and smartphones, which allow more than 2 billion
persons worldwide to have access to the Internet. This
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represents an unprecedented opportunity to collect and
communicate health-related information in real time and with
high geographical resolution, including individuals who do not
have contact with the healthcare system. Real-time surveil-
lance data are crucial for rapidly identifying public health
emergencies, optimizing the allocation of resources to respond
to them, and devising mitigation and containment measures.
Although existing disease surveillance systems (predomi-
nantly general practitioner (GP)-based but also involving
laboratory-based reporting, mandatory notifications, etc.) have
a fundamental role in monitoring and understanding the spread
of communicable diseases, they also have several important
limitations. One of the major issues is that, for diseases such as
influenza-like illness (ILI), only an unknown proportion of all
infected individuals see a doctor. In addition, consultations
frequently occur with a considerable delay, taking place only
when a complication has occurred or a doctor’s certificate is
required (for example, in Sweden such a certificate is not
required until after 1 week of absence from work). Other
issues concern: the time delay in data reporting and aggrega-
tion; the lack of information on the patterns of household
transmission; the lack of uniform standards for clinical
definitions, which may vary considerably between countries
and even between reporters (European Influenza Surveillance
Network). Furthermore, age-stratified rates of physician
consultation may vary widely with different healthcare and
health insurance systems. Healthcare-seeking behaviour can
change unpredictably during an epidemic, making extrapola-
tions of those statistics to the general population uncertain.
To overcome the above limitations in the existing infectious
diseases surveillance systems, with a focus on ILI, we proposed
an innovative information and communication technology
approach based on Web2.0 tools. Starting from the pivotal
and successful experiences with Internet-based monitoring
systems in The Netherlands and Portugal [2–4], the Influen-
zanet consortium undertook the challenge of deploying an
innovative real-time and interlinked surveillance system across
multiple European countries.
Materials and Methods
The first successful example of using the web for public health
purposes dates back to 2003, when, in The Netherlands and
Belgium, a Dutch scientific communication project was initi-
ated by the small company Science in Action. The purpose was
to inform the general population about influenza by means of a
self-reporting Internet platform in Dutch (http://www.degro-
tegriepmeting.nl), where volunteers in The Netherlands and
Belgium (the Flemish part) could answer socio-demographic,
medical and behavioural questions, and report their influenza-
related symptoms each week. User participation was achieved
through targeted communication and recruitment. A positive
side effect of this project was the collection of almost real-time
data about influenza, including from individuals who did not
visit a doctor when ill. Knowledge of volunteers’ postal codes
allowed the real-time collection of data at the postal code
level. Thanks to a vigorous communication campaign using
both online and offline media, the project attracted 20 000
users during this first season.
The possibility of collecting such detailed data about
influenza cases from such a wide audience attracted the
interest of the Gulbenkian Institute of Science Epidemiology
group in Portugal, who implemented their own platform in
Portuguese, and deployed the system at the beginning of the
2005 influenza season (http://www.gripenet.pt). In Portugal,
during the first 2 years of the project, approximately 5000
volunteers were attracted [3]. On the basis of this success, the
computational epidemiology group of the ISI Foundation in
Turin, Italy decided to deploy a similar platform during the
winter of 2007, to carry out influenza surveillance with the aim
of informing computational models for studying the spread of
ILI on a large scale. Data collected by these four platforms have
been evaluated [3,4] (Paolotti et al., 3rd International ICST
Conference on Electronic Healthcare for the 21st Century,
2010, Abstract no. 30), and the estimated seasonal influenza
incidence curves have been found to be in good agreement
with those from the former European Influenza Surveillance
Scheme.
Since 2009, the four Internet-based monitoring systems
have formed the foundation of a European-wide network of
platforms that became the key instrument for providing
real-time disease incidence for the epidemic forecast infra-
structure developed by the EU-funded research project
EPIWORK (http://www.epiwork.eu). The proposed network
of web platforms, called Influenzanet (http://www.influenzanet.
eu), saw, for the first time, the collaboration of epidemiolo-
gists, public health practitioners and modellers with the aim of
collecting epidemiological data in real time through the
contributions of Internet volunteers self-selected from among
the general population. The epidemiology teams devised
reference standard questionnaires for different diseases to
collect unified data across European countries (presented in
the supporting information). ILI has been the focus in the early
deployment of the system, but the final goal is to considerably
enlarge the portfolio of diseases and health conditions
monitored. In June 2009, the plans to export the platform to
other European countries were accelerated by the unfolding of
the H1N1 pandemic in the northern hemisphere. A web
system very similar to the Italian platform was rapidly deployed
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in the UK (https://flusurvey.org.uk/) to capture the whole
progress of the H1N1 pandemic, with the involvement of the
mathematical modelling group at the London School of
Hygiene and Tropical Medicine. This work allowed researchers
to detect the differences in healthcare-seeking behaviour
between different population groups and changes over time,
with significant implications for estimates of total case
numbers and the case-fatality rate [5,6].
The extension of the web platform in each country
represented a separate scientific challenge and research
problem, as the countries have different population stratifica-
tions and geographical distributions. The Influenzanet proto-
typical web platform implementation had to take into account
these differences and design specific mapping/representation
solutions, as well as find the optimal granularity for the data
acquisition and statistical sampling in the different countries. It
also had to provide easy management of content, news, and
info-graphics, and provide a user-friendly interface for the
volunteers to access the surveys aimed at collecting epidemi-
ological data.
The data collection revolves around two main surveys: a
background survey and a symptoms survey. The background
questionnaire is completed at registration, and contains
questions about the user’s postal code, gender, birth date,
household, level of education, employment, chronic health
conditions, smoking habits, etc. The symptoms questionnaire is
a weekly survey with a list of symptoms that the users employ
to describe their health status.
The platform is equipped with a ‘Reminder’, i.e. a weekly
email sent to users to remind them to fill in the symptoms
survey. These features were included in a plug-and-play
implementation to lessen the burden of deploying the platform
in new countries, and to let the local teams concentrate on the
communication and dissemination needed to attract partici-
pants, instead of having to deal with technical problems.
The new Influenzanet system started to be deployed in
October 2010. The localization, translation, testing and
fine-tuning activities took place between October 2010 and
February 2011. This powerful and flexible new platform has
been successfully adopted by all of the ‘old’ countries (The
Netherlands, Belgium, Portugal, the UK, and Italy), and, thanks
to its plug-and-play features, it was deployed, in December
2011, in Sweden by the Swedish Institute for Infectious Disease
Control, and by the Institut National de la Sante et de la
Recherche Medicale in France. In both cases, in <2 months,
the platform saw the enrolment of several thousands of
participants from all over the country. The system has since
been successfully deployed in Spain at the Instituto de
Biocomputacion y Fısica de Sistemas Complejos, at the
University of Saragoza, in September 2012, in Denmark at
the Statens Serum Institut in Copenhagen, and in Ireland at the
College of Engineering & Informatics, National University of
Ireland, Galway in August 2013.
All of the national platforms upload their data to a
centralized database, which provides uniform epidemiological
real-time data from >50 000 volunteers in ten European
countries.
Results and Discussion
The Influenzanet network for influenza surveillance in Europe
contains ten countries: The Netherlands, Belgium, Portugal,
Italy, the UK, Sweden, France, Spain, Ireland, and Denmark.
Identical questionnaires are implemented with questions about
respiratory symptoms, access to and utilization of care and
self-medication, uptake of vaccines, attitudes to influenza
vaccines, and absenteeism. The questionnaires can be used to
monitor ILI in the community in real time, to track vaccine
effectiveness [3,4,7,8], and to estimate risk factors for ILI (not
shown here).
In the ten countries, epidemiological data are collected with
the participation of a self-selected cohort followed over the
influenza season. The success of the data collection strongly
depends on the extent of participation of the volunteers
involved in the projects. The determinants of participation and
the representativeness of the self-selected cohorts of partic-
ipants in the various countries have been explored elsewhere
[9]. In order to assess how the web-based systems for ILI
surveillance can be a useful addition to the GP-based system,
we present the cross-year and cross-country incidence data,
which can be readily compared and easily collected, once the
platforms are in place. The national platforms collect data
about the health status of the active cohort volunteers during
the whole duration of the influenza season. Participants are
considered to be active if they have completed, on average, at
least one symptoms questionnaire every 3 weeks since the
registration. To define ILI, the following ILI case definition is
used, which resembles the WHO guidelines [10]: a sudden
onset of fever, namely, a measured body temperature of
≥38°C, accompanied by headache or muscle pain, and
accompanied by cough or a sore throat. The date of fever
onset is used as the date of ILI onset.
In Fig. 1, we show the weekly incidence calculated by
dividing the number of active participants with ILI in a
particular week by the total number of active participants in
the same week. Data from 2002–2003 to 2012–2013 for eight
countries (The Netherlands, Belgium, Portugal, Italy, the UK,
Sweden, France, and Spain) are shown. Ireland and Denmark
will start their data collection from 2013–2014. Data from the
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various countries have been previously published in separate
papers [2–7,11] (Paolotti et al., 3rd International ICST
Conference on Electronic Healthcare for the 21st Century,
2010).
These incidence curves can be compared with the incidence
rates as estimated from ILI consultations in the sentinel GP
network (http://ecdc.europa.eu/en/activities/surveillance/
EISN); this comparison shows very good agreement in the
peak time. With different definitions of ILI cases and active
participants, the incidence has the same trend, with a slight
difference in the peak amplitude, but not in the timing (not
shown). A more detailed figure for each country can be
downloaded at https://dl.dropboxusercontent.com/u/8418871/
influenzanet_supplementary.pdf.
In a few cases, such as Portugal in 2005 and Spain in 2012,
the incidence curves are not perfectly congruent with the
sentinel GP network data, because, for both countries, it was
the first season, and the number of volunteers contributing to
the data collection was very low at the beginning of the season,
and rapidly increased during the unfolding of the influenza
epidemics, leading to a noisy signal.
It is worth mentioning that the answers of Influenzanet
participants, when they were asked whether, during an ILI
episode, they consulted a GP, showed wide variability [3,4,7]
(Paolotti et al., 3rd International ICST Conference on Elec-
tronic Healthcare for the 21st Century, 2010) (Fig. 2) in the
various countries, showing that, more often than not, the web
platform can be of great advantage in collecting data about ILI
cases that would otherwise go undetected by GP surveillance.
The results show clearly the reliability and complementary
relevance of the participatory platform data.
Conclusions
The Influenzanet network of web-based platforms presented
here highlights the benefit of using the Internet to carry out
large-scale real-time surveillance for common diseases such as
influenza. Influenzanet relies on a flexible and readily deploy-
able web tool that is capable of coping with the requirements
of different countries regarding the data collection method,
either during a public health emergency or during an ordinary
influenza season. Internet surveillance of healthcare usage can
be used to complement traditional surveillance.
FIG. 1. Weekly incidence data (influenza-like illness cases/100 000) for eight countries from 2003–2004 to 2012–2013. All the curves are rescaled
on the maximum. Vertical lines correspond to months from November to May for each year. EISN, European Influenza Surveillance Network; BE,
Belgium; NL, The Netherlands; PT, Portugal; IT, Italy; FR, France; SE, Sweden; ES, Spain; UK, United Kingdom.
FIG. 2. Visits to general practitioners (GPs) reported by Influenzanet
users.
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